Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

Articles published in
JAMA
    April 2026
  1. LEFF B, Siu A, DeCherrie LV, Levine DM, et al
    Hospital at Home and Transforming US Health Care Delivery.
    JAMA. 2026 Apr 23. doi: 10.1001/jama.2026.4791.
    >> Share

  2. KUKOYI OM, Wang VS, Yao K, Cipriano CB, et al
    US State Actions Related to COVID-19 Vaccination Infrastructure and Access Amid Federal Shifts.
    JAMA. 2026 Apr 20:e265148. doi: 10.1001/jama.2026.5148.
    >> Share

  3. RUBIN R
    What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring.
    JAMA. 2026 Apr 17. doi: 10.1001/jama.2026.5535.
    >> Share

  4. ANDERER S
    US COVID-19 Deaths May Have Been Underreported, Study Finds.
    JAMA. 2026 Apr 3. doi: 10.1001/jama.2026.1032.
    >> Share

    February 2026
  5. ABBASI J
    Mechanisms Are Emerging for COVID-19 Vaccine-Associated Myocarditis.
    JAMA. 2026 Feb 6. doi: 10.1001/jama.2025.25866.
    >> Share

    January 2026
  6. ANDERER S
    US Skilled Nursing Facility Capacity Fell 5% Since COVID-19 Pandemic.
    JAMA. 2026 Jan 30. doi: 10.1001/jama.2025.26365.
    >> Share

  7. FATTAH M, Stoffel LA, Bubar KM, Bents SJ, et al
    Trends in County-Level Childhood Vaccination Exemptions in the US.
    JAMA. 2026 Jan 14:e2524407. doi: 10.1001/jama.2025.24407.
    >> Share

  8. DILEK S, Rosen J, Levashkevich A, Sharfstein JM, et al
    The US Food and Drug Administration's Regulation of Mifepristone.
    JAMA. 2026 Jan 12. doi: 10.1001/jama.2025.23091.
    >> Share

  9. PRASAD V, Makary MA
    FDA Labeling Change for mRNA COVID-19 Vaccines-Reply.
    JAMA. 2026 Jan 7. doi: 10.1001/jama.2025.21754.
    >> Share

  10. MEYEROWITZ EA
    FDA Labeling Change for mRNA COVID-19 Vaccines.
    JAMA. 2026 Jan 7. doi: 10.1001/jama.2025.21752.
    >> Share

  11. ANDERER S
    COVID-19 in Pregnancy Linked With Risk of Neurodevelopmental Disorders in Early Childhood.
    JAMA. 2026 Jan 2. doi: 10.1001/jama.2025.23090.
    >> Share

    December 2025
  12. DEVANAND DP, Wisniewski T, Razlighi Q, Qian M, et al
    Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial.
    JAMA. 2025 Dec 17:e2521738. doi: 10.1001/jama.2025.21738.
    >> Share

  13. MCCLYMONT E, Blitz S, Forward L, Cole S, et al
    The Role of Vaccination in Maternal and Perinatal Outcomes Associated With COVID-19 in Pregnancy.
    JAMA. 2025 Dec 15:e2521001. doi: 10.1001/jama.2025.21001.
    >> Share

  14. GIAMARELLOS-BOURBOULIS EJ, Kotsaki A, Kotsamidi I, Efthymiou A, et al
    Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial.
    JAMA. 2025 Dec 8:e2524175. doi: 10.1001/jama.2025.24175.
    >> Share

    November 2025
  15. PANT S
    2024-2025 COVID-19 Vaccines Protected Against JN.1 Subvariants.
    JAMA. 2025 Nov 14. doi: 10.1001/jama.2025.19733.
    >> Share

  16. FRIEDEN TR, Schaffner W, Sharfstein JM
    CDC's Failure to Recommend COVID-19 Vaccination-"Shared Clinical Decision-Making" Is Abdication of Responsibility.
    JAMA. 2025 Nov 13. doi: 10.1001/jama.2025.22473.
    >> Share

  17. PANT S
    New COVID-19 Vaccination Guidelines for Immunocompromised Individuals.
    JAMA. 2025 Nov 7. doi: 10.1001/jama.2025.19727.
    >> Share

    October 2025
  18. PANT S
    First-Trimester COVID-19 Vaccination Not Associated With Congenital Risks.
    JAMA. 2025 Oct 31. doi: 10.1001/jama.2025.17533.
    >> Share

  19. SCHWANDT H, Kowarski J, Woolf SH
    Life Expectancy After the COVID-19 Pandemic-Reply.
    JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.16405.
    >> Share

  20. WILSON KT, Esposito ML, Martinez A
    Life Expectancy After the COVID-19 Pandemic.
    JAMA. 2025 Oct 27. doi: 10.1001/jama.2025.16403.
    >> Share

  21. ABBASI J
    New Guidance on Cardiovascular Disease and COVID-19-From Infection to Long COVID to Vaccination.
    JAMA. 2025 Oct 24. doi: 10.1001/jama.2025.18834.
    >> Share

  22. SAUGEL B, Meidert AS, Brunkhorst FM, Bischoff R, et al
    Individualized Perioperative Blood Pressure Management in Patients Undergoing Major Abdominal Surgery: The IMPROVE-multi Randomized Clinical Trial.
    JAMA. 2025 Oct 12:e2517235. doi: 10.1001/jama.2025.17235.
    >> Share

  23. ANDERER S
    COVID-19 Linked to Lasting and Underrecognized Smell Impairment.
    JAMA. 2025 Oct 10. doi: 10.1001/jama.2025.17491.
    >> Share

  24. SHAH J
    Through the Glass.
    JAMA. 2025 Oct 9. doi: 10.1001/jama.2025.18165.
    >> Share

    September 2025
  25. ANDERER S
    Updated COVID-19 Vaccine Generates Strong Immune Response.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13887.
    >> Share

  26. ANDERER S
    Nasal Spray May Help Prevent COVID-19 Infection.
    JAMA. 2025 Sep 19. doi: 10.1001/jama.2025.13883.
    >> Share

  27. RUDMAN SPERGEL AK, Callendret B, Kostanyan L
    Influenza and COVID-19 Multicomponent Vaccine in Adults-Reply.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12225.
    >> Share

  28. LIU Z, Zhang L, Jiang M
    Influenza and COVID-19 Multicomponent Vaccine in Adults.
    JAMA. 2025 Sep 8. doi: 10.1001/jama.2025.12222.
    >> Share

  29. ANDERER S
    Breaking From CDC, ACOG Continues Recommending COVID-19 Vaccine During Pregnancy.
    JAMA. 2025 Sep 5. doi: 10.1001/jama.2025.16943.
    >> Share

    August 2025
  30. SURIE D, Self WH, Yuengling KA, Lauring AS, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons.
    JAMA. 2025 Aug 30:e2515896. doi: 10.1001/jama.2025.15896.
    >> Share

  31. ANDERER S
    COVID-19, Flu May Reawaken Dormant Cancer Cells.
    JAMA. 2025 Aug 29. doi: 10.1001/jama.2025.14772.
    >> Share

  32. ANDERER S
    COVID-19 Vaccines Averted 2.5 Million Deaths, Mostly Among Older Adults.
    JAMA. 2025 Aug 15. doi: 10.1001/jama.2025.11001.
    >> Share

  33. TURNER NA, Hamasaki T, Doernberg SB, Lodise TP, et al
    Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial.
    JAMA. 2025 Aug 13. doi: 10.1001/jama.2025.12543.
    >> Share

  34. ANDERER S
    Booster Shots Help Prevent Severe COVID-19 in People With Cancer.
    JAMA. 2025 Aug 8. doi: 10.1001/jama.2025.10996.
    >> Share

  35. RUBIN R
    SARS-CoV-2 Variants Challenge Surveillance Efforts and COVID-19 Vaccines.
    JAMA. 2025 Aug 1. doi: 10.1001/jama.2025.12273.
    >> Share

    July 2025
  36. BAKER LD, Espeland MA, Whitmer RA, Snyder HM, et al
    Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial.
    JAMA. 2025 Jul 28:e2512923. doi: 10.1001/jama.2025.12923.
    >> Share

  37. SCHNEIDER L
    WHO Report Suggests Likely Zoonotic Origin of COVID-19, Doesn't Rule Out Lab Leak.
    JAMA. 2025 Jul 25. doi: 10.1001/jama.2025.10976.
    >> Share

  38. PRASAD V, Makary MA
    US FDA Safety Labeling Change for mRNA COVID-19 Vaccines.
    JAMA. 2025 Jul 14. doi: 10.1001/jama.2025.12675.
    >> Share

  39. RUBIN R
    The CDC No Longer Recommends COVID-19 Shots During Pregnancy-Now What?
    JAMA. 2025 Jul 11. doi: 10.1001/jama.2025.11889.
    >> Share

  40. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al
    The Failure of Life Expectancy to Fully Rebound to Prepandemic Levels.
    JAMA. 2025 Jul 9:e2510439. doi: 10.1001/jama.2025.10439.
    >> Share

  41. STAR J, Bandi P
    Cancer Screening After the Onset of the COVID-19 Pandemic-Reply.
    JAMA. 2025 Jul 7. doi: 10.1001/jama.2025.6934.
    >> Share

  42. WU G, Yin J, Huang Y
    Cancer Screening After the Onset of the COVID-19 Pandemic.
    JAMA. 2025 Jul 7. doi: 10.1001/jama.2025.6931.
    >> Share

    June 2025
  43. GRUNEBAUM A, Chervenak FA
    Professional Responsibility for COVID-19 Vaccination in Pregnancy.
    JAMA. 2025 Jun 25. doi: 10.1001/jama.2025.11328.
    >> Share

  44. GOSTIN LO, Reiss D, Offit PA
    Changed Recommendations for COVID-19 Vaccines for Children and Pregnant Women: A Failure of Process, Policy, and Science.
    JAMA. 2025 Jun 13. doi: 10.1001/jama.2025.10658.
    >> Share

  45. ZETTLER PJ, Cha S, Despres S, Lurie P, et al
    FDA Review of Novavax's COVID-19 Vaccine-Regulatory Integrity and Deviations From Standard Practice.
    JAMA. 2025 Jun 9. doi: 10.1001/jama.2025.9898.
    >> Share

  46. NGUYEN T, Whaley C, Simon KI, Cantor J, et al
    Health Care Workforce Recovery After the End of the COVID-19 Emergency.
    JAMA. 2025 Jun 5. doi: 10.1001/jama.2025.8588.
    >> Share

    May 2025
  47. RUDMAN SPERGEL AK, Wu I, Deng W, Cardona J, et al
    Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults >/=50 Years: A Randomized Clinical Trial.
    JAMA. 2025 May 7:e255646. doi: 10.1001/jama.2025.5646.
    >> Share

    April 2025
  48. KIANG MV, Bubar KM, Maldonado Y, Hotez PJ, et al
    Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.
    JAMA. 2025 Apr 24. doi: 10.1001/jama.2025.6495.
    >> Share

  49. MOIN EE, Seewald NJ, Halpern SD
    Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.
    JAMA. 2025 Apr 14:e252163. doi: 10.1001/jama.2025.2163.
    >> Share

    March 2025
  50. LAURING AS, Edson C, Surie D, Dawood FS, et al
    Genomic Characterization of RSV in the US by Vaccination Status.
    JAMA. 2025 Mar 10. doi: 10.1001/jama.2025.1225.
    >> Share

  51. STAR J, Han X, Smith RA, Schafer EJ, et al
    Cancer Screening 3 Years After the Onset of the COVID-19 Pandemic.
    JAMA. 2025 Mar 5:e250902. doi: 10.1001/jama.2025.0902.
    >> Share

    February 2025
  52. HANLON P, Butterly E, Wei L, Wightman H, et al
    Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
    JAMA. 2025 Feb 3:e2427402. doi: 10.1001/jama.2024.27402.
    >> Share

    January 2025
  53. ANDERER S
    COVID-19 Tied to Long-Term Kidney Function Decline.
    JAMA. 2025 Jan 24. doi: 10.1001/jama.2024.28058.
    >> Share

    December 2024
  54. RUBIN R
    In Search of COVID-19 Vaccines That Elicit Mucosal Immunity and Stop Transmission.
    JAMA. 2024 Dec 20. doi: 10.1001/jama.2024.23627.
    >> Share

  55. GENG LN, Erlandson KM, Hornig M, Letts R, et al
    2024 Update of the RECOVER-Adult Long COVID Research Index.
    JAMA. 2024 Dec 18. doi: 10.1001/jama.2024.24184.
    >> Share

  56. ANDERER S
    New Research Suggests Increased Risk of Some Autoimmune Disorders After COVID-19.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.24894.
    >> Share

  57. ANDERER S
    Trial Shows It's Safe to Get COVID-19, Flu Vaccines at the Same Time.
    JAMA. 2024 Dec 13. doi: 10.1001/jama.2024.24891.
    >> Share

  58. MAIA IS, Kawano-Dourado L, Tramujas L, de Oliveira NE, et al
    High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial.
    JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26244.
    >> Share

  59. ANDERER S
    CDC Recommends Second COVID-19 Vaccine Dose for Older Adults.
    JAMA. 2024 Dec 6. doi: 10.1001/jama.2024.24258.
    >> Share

    November 2024
  60. RUBIN R
    What to Know About XEC, the New SARS-CoV-2 Variant Expected to Dominate Winter's COVID-19 Wave.
    JAMA. 2024 Nov 22. doi: 10.1001/jama.2024.24481.
    >> Share

  61. ANDERER S
    Early COVID-19 Infections Linked With Higher Heart Attack, Stroke Risk.
    JAMA. 2024 Nov 15. doi: 10.1001/jama.2024.23045.
    >> Share

  62. ANDERER S
    FDA Authorizes First At-Home COVID-19 and Flu Combo Test.
    JAMA. 2024 Nov 8. doi: 10.1001/jama.2024.22561.
    >> Share

    October 2024
  63. TADROUS M, Callaway Kim K, Hernandez I, Rothenberger SD, et al
    Differences in Drug Shortages in the US and Canada.
    JAMA. 2024 Oct 31. doi: 10.1001/jama.2024.17688.
    >> Share

  64. ANDERER S
    HHS Will Provide Free US-Made COVID-19 Tests to Households.
    JAMA. 2024 Oct 25. doi: 10.1001/jama.2024.21819.
    >> Share


  65. Audio Highlights: September 14-20, 2024.
    JAMA. 2024;332:e2318402.
    >> Share

  66. HABIB AR, Ijaz N
    Public Health Crisis in Gaza-Reply.
    JAMA. 2024;332:1305-1306.
    >> Share

  67. PATEL P, Wentworth DE, Daskalakis D
    COVID-19 Therapeutics for Nonhospitalized Older Adults.
    JAMA. 2024 Oct 7. doi: 10.1001/jama.2024.16460.
    >> Share

    September 2024
  68. ANDERER S
    Caseload Strain Contributed to 1 in 5 COVID-19 Deaths at US Hospitals.
    JAMA. 2024 Sep 27. doi: 10.1001/jama.2024.19687.
    >> Share

  69. ANDERER S
    FDA Approves Updated COVID-19 Vaccines.
    JAMA. 2024 Sep 20. doi: 10.1001/jama.2024.19127.
    >> Share

  70. LIM JK, Ramgopal S, Hoffmann JA, Lorenz D, et al
    Characteristics and Trends of Prehospital Encounters for Opioid Overdoses Among US Youth, 2018-2022.
    JAMA. 2024 Sep 18:e2417341. doi: 10.1001/jama.2024.17341.
    >> Share

  71. AMBA V, Cooper MSL, Sommers BD
    History Repeats-The Election Battle for Medicaid in 2024.
    JAMA. 2024;332:867-868.
    >> Share

  72. VAUGHN VM, Dickson RP, Horowitz JK, Flanders SA, et al
    Community-Acquired Pneumonia: A Review.
    JAMA. 2024 Sep 16. doi: 10.1001/jama.2024.14796.
    >> Share

  73. ANDERER S
    Combo COVID-19 and Flu mRNA Vaccine Falls Short of Total Flu Protection.
    JAMA. 2024 Sep 13. doi: 10.1001/jama.2024.18194.
    >> Share

  74. BOCK A
    New Guidance Helps Clinicians Use Pemivibart to Protect Immunocompromised Patients From COVID-19.
    JAMA. 2024 Sep 13. doi: 10.1001/jama.2024.18589.
    >> Share

  75. ANDERER S
    CDC: Overall Deaths, Especially From COVID-19, Lower in 2023.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.17606.
    >> Share

  76. RUBIN R
    The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits.
    JAMA. 2024 Sep 6. doi: 10.1001/jama.2024.16432.
    >> Share

  77. SURIE D, Self WH, Zhu Y, Yuengling KA, et al
    RSV Vaccine Effectiveness Against Hospitalization Among US Adults 60 Years and Older.
    JAMA. 2024 Sep 4:e2415775. doi: 10.1001/jama.2024.15775.
    >> Share


  78. Audio Highlights.
    JAMA. 2024;332:e2318388.
    >> Share

    August 2024
  79. WOOLF SH
    Increasing Mortality Rates in the US, but Not From COVID-19.
    JAMA. 2024 Aug 29. doi: 10.1001/jama.2024.13626.
    >> Share

  80. SEMENZATO L, Le Vu S, Botton J, Bertrand M, et al
    Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies.
    JAMA. 2024 Aug 26:e2416380. doi: 10.1001/jama.2024.16380.
    >> Share

  81. ANDERER S
    Widespread SARS-CoV-2 Exposure Among Wildlife in the US.
    JAMA. 2024 Aug 23. doi: 10.1001/jama.2024.15877.
    >> Share

  82. GROSS RS, Thaweethai T, Kleinman LC, Snowden JN, et al
    Characterizing Long COVID in Children and Adolescents.
    JAMA. 2024 Aug 21:e2412747. doi: 10.1001/jama.2024.12747.
    >> Share

  83. AHMAD FB, Cisewski JA, Anderson RN
    Leading Causes of Death in the US, 2019-2023.
    JAMA. 2024 Aug 8. doi: 10.1001/jama.2024.15563.
    >> Share

  84. WARE LB, Files DC, Fowler A, Aboodi MS, et al
    Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.
    JAMA. 2024;332:390-400.
    >> Share

  85. HARRIS E
    NIH Starts Testing Nasal COVID-19 Vaccine in US.
    JAMA. 2024 Aug 2. doi: 10.1001/jama.2024.13769.
    >> Share

    July 2024
  86. HARRIS E
    COVID-19 Vaccination in Early Pregnancy Not Linked to Birth Defects.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13389.
    >> Share

  87. YOUMSHAJEKIAN L
    COVID-19 May Protect Against the Common Cold-Here's Why Knowing That Could Lead to Better Vaccines.
    JAMA. 2024 Jul 26. doi: 10.1001/jama.2024.13382.
    >> Share

  88. AGARWAL SD, Cook BL, Liebman JB
    Effect of Cash Benefits on Health Care Utilization and Health: A Randomized Study.
    JAMA. 2024 Jul 22:e2413004. doi: 10.1001/jama.2024.13004.
    >> Share

  89. FRIEDL N, Sporreiter M, Winkler C, Heublein A, et al
    Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection.
    JAMA. 2024 Jul 15:e2411174. doi: 10.1001/jama.2024.11174.
    >> Share

  90. HARRIS E
    Symptoms After COVID-19 Vaccination Tied to Higher Antibody Levels.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.12231.
    >> Share

  91. RUBIN R
    Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky.
    JAMA. 2024 Jul 12. doi: 10.1001/jama.2024.10992.
    >> Share

  92. HARRIS E
    Review Calls for Standardized Long COVID Definition.
    JAMA. 2024;332:97.
    >> Share

  93. FANG Z, Ahrnsbrak R, Rekito A
    Evidence Mounts That About 7% of US Adults Have Had Long COVID.
    JAMA. 2024;332:5-6.
    >> Share

    June 2024
  94. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    >> Share

  95. PIRRACCHIO R, Venkatesh B, Legrand M
    Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.6096.
    >> Share

  96. ABDUL-AZIZ MH, Hammond NE, Brett SJ, Cotta MO, et al
    Prolonged vs Intermittent Infusions of beta-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.
    JAMA. 2024 Jun 12:e249803. doi: 10.1001/jama.2024.9803.
    >> Share

  97. DEAN N, Amin AB
    Test-Negative Study Designs for Evaluating Vaccine Effectiveness.
    JAMA. 2024 Jun 12. doi: 10.1001/jama.2024.5633.
    >> Share

  98. VAN DER LINDEN S, Roozenbeek J
    "Inoculation" to Resist Misinformation.
    JAMA. 2024;331:1961-1962.
    >> Share

  99. ANGUS DC, Huang AJ, Lewis RJ, Abernethy AP, et al
    The Integration of Clinical Trials With the Practice of Medicine: Repairing a House Divided.
    JAMA. 2024 Jun 3. doi: 10.1001/jama.2024.4088.
    >> Share

    May 2024
  100. HARRIS E
    Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
    >> Share

  101. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    >> Share

  102. HARRIS E
    Microneedle Vaccine Patches Generated Immune Response in Children.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
    >> Share

  103. BOCK A
    Researchers See Hope in Symptom-Guided Exercise for Long COVID With Postexertional Malaise.
    JAMA. 2024;331:1609-1611.
    >> Share

  104. DEVEREUX G, Cotton S, Nath M, McMeekin N, et al
    Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.
    JAMA. 2024 May 19. doi: 10.1001/jama.2024.8771.
    >> Share

  105. RUBIN R
    Combined Vaccines Against COVID-19, Flu, and Other Respiratory Illnesses Could Soon Be Available.
    JAMA. 2024 May 17. doi: 10.1001/jama.2024.7370.
    >> Share

  106. XIE Y, Choi T, Al-Aly Z
    Mortality in Patients Hospitalized for COVID-19 vs Influenza in Fall-Winter 2023-2024.
    JAMA. 2024 May 15:e247395. doi: 10.1001/jama.2024.7395.
    >> Share


  107. Audio Highlights.
    JAMA. 2024;331:e2318283.
    >> Share

  108. WEN X, Yan J, Zhu Z
    Apixaban to Prevent Recurrence After Cryptogenic Stroke.
    JAMA. 2024 May 13. doi: 10.1001/jama.2024.6848.
    >> Share

  109. HARRIS E
    National Academies Report: COVID-19 Vaccines Don't Cause Many Potential Harms.
    JAMA. 2024 May 10. doi: 10.1001/jama.2024.7724.
    >> Share

  110. HARRIS E
    Trials Will Evaluate Treatments for Long COVID Nervous System Problems.
    JAMA. 2024;331:1439-1440.
    >> Share

  111. AGRAWAL S, Ross JS, Ramachandran R
    Implications for Public Health Regulation if Chevron Deference Is Overturned.
    JAMA. 2024;331:1443-1444.
    >> Share

  112. CHESHIRE WP, Dudenkov DV, Munipalli B
    Tilt Table Testing.
    JAMA. 2024;331:1494-1495.
    >> Share

    April 2024
  113. HARRIS E
    WHO Launches Broad Coronavirus Surveillance Network.
    JAMA. 2024 Apr 26. doi: 10.1001/jama.2024.6724.
    >> Share

  114. ALLEN MR, Desai N, Namazi A, Leas E, et al
    Characteristics of X (Formerly Twitter) Community Notes Addressing COVID-19 Vaccine Misinformation.
    JAMA. 2024 Apr 24:e244800. doi: 10.1001/jama.2024.4800.
    >> Share

  115. HARRIS E
    Meta-Analysis: "Limited" Benefits to Rapid Viral Tests in EDs.
    JAMA. 2024;331:1355.
    >> Share

  116. HARRIS E
    Deaths From Excessive Drinking Rose in the US During Pandemic.
    JAMA. 2024;331:1355.
    >> Share

  117. IMPERIALE TF, Lavin P, Ransohoff DF
    Multitarget Stool RNA Testing.
    JAMA. 2024;331:1418.
    >> Share

  118. BAIRD G
    Multitarget Stool RNA Testing.
    JAMA. 2024;331:1418-1419.
    >> Share

  119. BARNELL EK, Lieberman DA
    Multitarget Stool RNA Testing-Reply.
    JAMA. 2024;331:1419-1420.
    >> Share

  120. HARRIS E
    Antidepressant Prescriptions for Female Teens Surged After Pandemic.
    JAMA. 2024;331:1266.
    >> Share

  121. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    >> Share

  122. ANDERER S
    Could "Empathetic Refutation" Help Clinicians Sway Vaccine Skeptics?
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.4493.
    >> Share

  123. DAWOOD FS, Payne AB, McMorrow ML
    Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
    JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.
    >> Share

  124. ANDERER S
    Study: 1 of Every 9 US Cancer Cases Missed During 2020 Pandemic.
    JAMA. 2024;331:1082.
    >> Share

  125. GUSSIN GM, McKinnell JA, Singh RD, Miller LG, et al
    Reducing Hospitalizations and Multidrug-Resistant Organisms via Regional Decolonization in Hospitals and Nursing Homes.
    JAMA. 2024 Apr 1:e242759. doi: 10.1001/jama.2024.2759.
    >> Share

    March 2024
  126. HARRIS E
    COVID-19 Infection Tied to Slight Cognitive Deficits.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2087.
    >> Share

  127. HARRIS E
    COVID-19 Associated With Higher Risk of Autoimmune Diseases.
    JAMA. 2024 Mar 22. doi: 10.1001/jama.2024.2092.
    >> Share

  128. LU Y, Matuska K, Nadimpalli G, Ma Y, et al
    Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults.
    JAMA. 2024;331:938-950.
    >> Share

  129. NIELSEN FM, Klitgaard TL, Siegemund M, Laake JH, et al
    Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial.
    JAMA. 2024 Mar 19:e242934. doi: 10.1001/jama.2024.2934.
    >> Share

  130. SCHWARTZSTEIN RM
    Oxygen Supplementation in COVID-19-How Much Is Enough?
    JAMA. 2024 Mar 19. doi: 10.1001/jama.2024.2935.
    >> Share

  131. HARRIS E
    CDC Tracking BA.2.87.1, New Omicron Subvariant With Potential to Evade Immunity.
    JAMA. 2024;331:907.
    >> Share

  132. ANDERER S
    CDC Recommends Additional COVID-19 Booster for Older Adults.
    JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
    >> Share

  133. MCKENZIE C, Moore L, Borthwick M
    Vitamin C for Patients Hospitalized With COVID-19.
    JAMA. 2024;331:886.
    >> Share

  134. ADHIKARI NKJ, Lamontagne F
    Vitamin C for Patients Hospitalized With COVID-19-Reply.
    JAMA. 2024;331:886-887.
    >> Share

  135. HARRIS E
    Virtual Group Exercise Program Improved Long COVID Symptoms.
    JAMA. 2024;331:822.
    >> Share

  136. HARRIS E
    Better Outcomes When Kidney Damage Is From COVID-19.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1574.
    >> Share

  137. HARRIS E
    HPV Vaccination Rates Stagnated During COVID-19 Pandemic.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1569.
    >> Share

  138. HARRIS E
    Millions of US Children Experience Range of Long COVID Effects.
    JAMA. 2024;331:726.
    >> Share

    February 2024
  139. ANDERSSON NW, Thiesson EM, Hviid A
    Adverse Events After XBB.1.5-Containing COVID-19 mRNA Vaccines.
    JAMA. 2024 Feb 26:e241036. doi: 10.1001/jama.2024.1036.
    >> Share

  140. HARRIS E
    New Antiviral on the Horizon for Mild to Moderate COVID-19.
    JAMA. 2024 Feb 21. doi: 10.1001/jama.2024.0729.
    >> Share

  141. GRAETZ N, Hepburn P, Gershenson C, Porter SR, et al
    Examining Excess Mortality Associated With the COVID-19 Pandemic for Renters Threatened With Eviction.
    JAMA. 2024;331:592-600.
    >> Share

  142. RUBIN R
    When It Comes to SARS-CoV-2 Clearance, People Who are Immunocompromised Are Not All Alike.
    JAMA. 2024 Feb 14. doi: 10.1001/jama.2024.1014.
    >> Share

  143. NORMAN M, Magnus MC, Soderling J, Juliusson PB, et al
    Neonatal Outcomes After COVID-19 Vaccination in Pregnancy.
    JAMA. 2024;331:396-407.
    >> Share

  144. FELDSTEIN LR, Britton A, Grant L, Wiegand R, et al
    Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
    JAMA. 2024;331:408-416.
    >> Share

    January 2024
  145. HARRIS E
    Missed Vaccine Doses Tied to Worse COVID-19 Outcomes.
    JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28340.
    >> Share

  146. RUBIN R
    Paxlovid Is Effective but Underused-Here's What the Latest Research Says About Rebound and More.
    JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28254.
    >> Share

  147. RUBIN R
    As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".
    JAMA. 2024 Jan 12. doi: 10.1001/jama.2023.27841.
    >> Share

  148. RUBIN R
    From "Immunity Debt" to "Immunity Theft"-How COVID-19 Might Be Tied to Recent Respiratory Disease Surges.
    JAMA. 2024 Jan 10. doi: 10.1001/jama.2023.26608.
    >> Share

  149. KAPOOR N, Dietz C, Buettner BP
    An Incarcerated Individual With Weight Loss and Interstitial Pulmonary Infiltrates.
    JAMA. 2024 Jan 8. doi: 10.1001/jama.2023.24260.
    >> Share

  150. MARKS P, Califf R
    Is Vaccination Approaching a Dangerous Tipping Point?
    JAMA. 2024 Jan 5. doi: 10.1001/jama.2023.27685.
    >> Share

  151. HARRIS E
    Long COVID in Nursing Home Residents Manifests as Functional Decline.
    JAMA. 2024;331:15.
    >> Share

    December 2023
  152. HARRIS E
    Disproportionate Death Rates Reported in US Prisons Early in the COVID-19 Pandemic.
    JAMA. 2023 Dec 27. doi: 10.1001/jama.2023.25770.
    >> Share

  153. HARRIS E
    Using Throat Swabs Improved Sensitivity in Detecting SARS-CoV-2.
    JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25267.
    >> Share

  154. HARRIS E
    Program Offering Free COVID-19 and Flu Services Expands Nationwide.
    JAMA. 2023 Dec 20. doi: 10.1001/jama.2023.25268.
    >> Share

  155. HARRIS E
    Life Expectancy in US Climbed After Declines Related to COVID-19.
    JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24683.
    >> Share

  156. SURAN M
    Studies Investigate Whether Antivirals Like Paxlovid May Prevent Long COVID.
    JAMA. 2023 Dec 13. doi: 10.1001/jama.2023.24103.
    >> Share

  157. RUBIN R
    Up the Nose and Down the Windpipe May Be the Path to New and Improved COVID-19 Vaccines.
    JAMA. 2023 Dec 6. doi: 10.1001/jama.2023.0644.
    >> Share

  158. MATHEW P, Feldmann M
    Treatment of Adults Hospitalized With COVID-19 Pneumonia.
    JAMA. 2023;330:2122-2123.
    >> Share

  159. POWDERLY WG, LaVange L, Bozzette SA
    Treatment of Adults Hospitalized With COVID-19 Pneumonia-Reply.
    JAMA. 2023;330:2123.
    >> Share

  160. SCHMIDT M, Hajage D, Lebreton G, Dres M, et al
    Prone Positioning During Extracorporeal Membrane Oxygenation in Patients With Severe ARDS: The PRONECMO Randomized Clinical Trial.
    JAMA. 2023 Dec 1. doi: 10.1001/jama.2023.24491.
    >> Share

    November 2023
  161. EASTMAN Q
    Study Shows Businesses Selling Unapproved Stem Cell Treatments Have Turned to Long COVID.
    JAMA. 2023 Nov 29. doi: 10.1001/jama.2023.23897.
    >> Share

  162. BERGMAN C
    Treatment of SARS-CoV-2 Infection in US Nursing Homes.
    JAMA. 2023;330:2021-2022.
    >> Share

  163. MCGARRY BE, Sommers BD, Barnett ML
    Treatment of SARS-CoV-2 Infection in US Nursing Homes-Reply.
    JAMA. 2023;330:2022.
    >> Share

  164. HARRIS E
    COVID Moonshot Drove Discovery of Potential COVID-19 Antivirals.
    JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22934.
    >> Share

  165. HARRIS E
    Smell, Taste Issues After Mild COVID-19 Resolve Over 3 Years.
    JAMA. 2023 Nov 22. doi: 10.1001/jama.2023.22930.
    >> Share

  166. HARRIS E
    Long COVID Linked With Viral Persistence, Serotonin Decline.
    JAMA. 2023;330:1827.
    >> Share

  167. HARRIS E
    Audit Finds US National Stockpile "Was Not Equipped" for the Pandemic.
    JAMA. 2023;330:1828.
    >> Share

  168. STEWART TG, Rebolledo PA, Mourad A, Lindsell CJ, et al
    Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
    JAMA. 2023 Nov 17:e2323363. doi: 10.1001/jama.2023.23363.
    >> Share

  169. HARRIS E
    Combined COVID-19, Flu Vaccine Candidate Headed to Phase 3 Trials.
    JAMA. 2023 Nov 15. doi: 10.1001/jama.2023.22353.
    >> Share

  170. HARRIS E
    Convalescent Plasma Lowered Risk of Death in COVID-19 ARDS.
    JAMA. 2023 Nov 8. doi: 10.1001/jama.2023.21872.
    >> Share

  171. HARRIS E
    HRSA Study: US Abortions Decreased 14% During COVID-19.
    JAMA. 2023 Nov 1. doi: 10.1001/jama.2023.21178.
    >> Share

    October 2023
  172. ADHIKARI NKJ, Hashmi M, Tirupakuzhi Vijayaraghavan BK, Haniffa R, et al
    Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
    JAMA. 2023 Oct 25:e2321407. doi: 10.1001/jama.2023.21407.
    >> Share

  173. JABALEY CS, Coopersmith CM
    Vitamin C for Patients With COVID-19: More Evidence of Lack of Efficacy in Patients With Sepsis.
    JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.18592.
    >> Share

  174. HARRIS E
    US Survey: About 7% of Adults, 1% of Children Have Had Long COVID.
    JAMA. 2023;330:1516.
    >> Share

  175. HARRIS E
    COVID-19 Hospitalizations Up Among Older Adults.
    JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19796.
    >> Share

  176. HARRIS E
    Previous COVID-19 Linked With Autoimmune Conditions.
    JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19798.
    >> Share

  177. BATRA A, Nath A, Koralnik IJ
    Postacute Sequelae of SARS-CoV-2 Infection.
    JAMA. 2023;330:1491-1492.
    >> Share

  178. THAWEETHAI T, Foulkes AS
    Postacute Sequelae of SARS-CoV-2 Infection-Reply.
    JAMA. 2023;330:1492.
    >> Share

  179. HARRIS E
    Exercise Programs Might Improve Long COVID.
    JAMA. 2023;330:1421.
    >> Share

  180. SIEGAL DM, Belley-Cote EP, Lee SF, Hill S, et al
    Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical Trial.
    JAMA. 2023 Oct 12. doi: 10.1001/jama.2023.20820.
    >> Share

  181. RAASVELD SJ, de Bruin S, Reuland MC, van den Oord C, et al
    Red Blood Cell Transfusion in the Intensive Care Unit.
    JAMA. 2023 Oct 12. doi: 10.1001/jama.2023.20737.
    >> Share

  182. HARRIS E
    Changes in SARS-CoV-2 Sequence Linked With Antiviral Use.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19202.
    >> Share

    September 2023
  183. CHEW KW, Malani PN, Gandhi RT
    COVID-19 Therapeutics for Nonhospitalized Patients-Updates and Future Directions.
    JAMA. 2023 Sep 29. doi: 10.1001/jama.2023.19542.
    >> Share

  184. HARRIS E
    Some People Still Have Long COVID Symptoms After 2 Years.
    JAMA. 2023;330:1127.
    >> Share

  185. RUBIN R
    Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months.
    JAMA. 2023 Sep 18. doi: 10.1001/jama.2023.19759.
    >> Share

  186. TARTOF SY, Frankland TB, Slezak JM, Puzniak L, et al
    Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17473.
    >> Share

  187. DEL RIO C, Malani PN
    COVID-19 in the Fall of 2023-Forgotten but Not Gone.
    JAMA. 2023 Sep 12. doi: 10.1001/jama.2023.19049.
    >> Share

  188. HARRIS E
    Two New Analyses Add to Long COVID Understanding.
    JAMA. 2023;330:905-906.
    >> Share

  189. LUGAR M, Eugster A, Achenbach P, von dem Berge T, et al
    SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood.
    JAMA. 2023 Sep 8. doi: 10.1001/jama.2023.16348.
    >> Share

  190. HARRIS E
    High Blood Pressure More Likely After COVID-19 Than Flu.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16676.
    >> Share

  191. HARRIS E
    HHS To Invest $1.4 Billion in New COVID-19 Vaccines, Therapies.
    JAMA. 2023 Sep 6. doi: 10.1001/jama.2023.16678.
    >> Share

  192. HARRIS E
    Federal Government Announces Long COVID Trials, Research Office.
    JAMA. 2023;330:797.
    >> Share

  193. KENTISH-BARNES N, Resche-Rigon M, Lafarge A, Souppart V, et al
    PTSD Symptoms Among Family Members of Patients With ARDS Caused by COVID-19 After 12 Months.
    JAMA. 2023 Sep 1. doi: 10.1001/jama.2023.15879.
    >> Share

    August 2023
  194. HARRIS E
    Severe COVID-19 Linked to Enduring Immune System Changes.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16109.
    >> Share

  195. HARRIS E
    CDC Assesses Risk From BA.2.86, Highly Mutated COVID-19 Variant.
    JAMA. 2023 Aug 30. doi: 10.1001/jama.2023.16105.
    >> Share

  196. HARRIS E
    Lung Transplants for COVID-19 Similarly Successful.
    JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15450.
    >> Share

  197. YOO SGK, Chung GS, Bahendeka SK, Sibai AM, et al
    Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries.
    JAMA. 2023;330:715-724.
    >> Share

  198. ABBASI J
    What to Know About EG.5, the Latest SARS-CoV-2 "Variant of Interest".
    JAMA. 2023 Aug 18. doi: 10.1001/jama.2023.16498.
    >> Share

  199. RAGLOW Z, Malani PN, Petty LA
    Outpatient Treatment for COVID-19.
    JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.16666.
    >> Share

  200. RUBIN R
    Why Blood Type Seems to Be Linked With COVID-19 Risk.
    JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.15996.
    >> Share

  201. DOS SANTOS RAS, Taccone FS, Annoni F
    Renin-Angiotensin System Modulation in Adults With COVID-19.
    JAMA. 2023;330:663-664.
    >> Share

  202. SELF WH, DeClercq J, Orr M
    Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
    JAMA. 2023;330:664-665.
    >> Share

  203. HARRIS E
    Case of Middle East Respiratory Syndrome Coronavirus Confirmed.
    JAMA. 2023 Aug 2. doi: 10.1001/jama.2023.13618.
    >> Share

  204. ABBASI J
    A Genetic Explanation for Why Some People Had Asymptomatic COVID-19.
    JAMA. 2023 Aug 2. doi: 10.1001/jama.2023.14703.
    >> Share

  205. DAVIDSON BL, Levi MM
    Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    JAMA. 2023;330:471-472.
    >> Share

  206. GOLIGHER EC, Lawler PR, Zarychanski R
    Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19-Reply.
    JAMA. 2023;330:472-473.
    >> Share

    July 2023
  207. SURAN M
    HHS Urges Primary Care Clinicians to Help Patients Manage Long COVID's Mental Health Symptoms.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13605.
    >> Share

  208. HARRIS E
    Free COVID-19 Vaccinations on the Way for Uninsured Adults.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133.
    >> Share

  209. GLEASON JL, Tamburro R, Signore C
    Promoting Data Harmonization of COVID-19 Research in Pregnant and Pediatric Populations.
    JAMA. 2023 Jul 20. doi: 10.1001/jama.2023.10835.
    >> Share

  210. MCGARRY BE, Sommers BD, Wilcock AD, Grabowski DC, et al
    Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes.
    JAMA. 2023 Jul 14:e2312945. doi: 10.1001/jama.2023.12945.
    >> Share

  211. O'HALLORAN JA, Ko ER, Anstrom KJ, Kedar E, et al
    Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
    JAMA. 2023 Jul 10:e2311043. doi: 10.1001/jama.2023.11043.
    >> Share

  212. RUBIN R
    This Fall's COVID-19 Vaccines Will Target Omicron XBB Subvariants, but Who Needs Them Remains to Be Seen.
    JAMA. 2023 Jul 5. doi: 10.1001/jama.2023.10053.
    >> Share

    June 2023
  213. HARRIS E
    Patients With COVID-19 and Fungal Infections Had High Mortality Rates.
    JAMA. 2023 Jun 28. doi: 10.1001/jama.2023.11957.
    >> Share

  214. MICHAELS D, Wagner GR, Ryan L
    Lessons From COVID-19 for Protecting Workers in the Next Pandemic.
    JAMA. 2023 Jun 16. doi: 10.1001/jama.2023.8229.
    >> Share

  215. ANDREWS N, Stowe J, Miller E, Ramsay M, et al
    BA.1 Bivalent COVID-19 Vaccine Use and Stroke in England.
    JAMA. 2023 Jun 15. doi: 10.1001/jama.2023.10123.
    >> Share

  216. HARRIS E
    Hybrid COVID-19 Immunity Common by Fall of 2022.
    JAMA. 2023 Jun 14. doi: 10.1001/jama.2023.10399.
    >> Share

  217. LANDON E
    An Apple a Day.
    JAMA. 2023 Jun 8. doi: 10.1001/jama.2023.8957.
    >> Share

  218. HARRIS E
    FDA Grants Full Approval to Paxlovid, COVID-19 Antiviral Treatment.
    JAMA. 2023 Jun 7. doi: 10.1001/jama.2023.9925.
    >> Share

  219. DAHNE J, Hawk LW Jr
    Health Equity and Decentralized Trials.
    JAMA. 2023 Jun 1. doi: 10.1001/jama.2023.6982.
    >> Share

    May 2023
  220. GROSS R, Lo Re V 3rd
    Disentangling the Postacute Sequelae of SARS-CoV-2: E Unibus Pluram (From One, Many).
    JAMA. 2023 May 25. doi: 10.1001/jama.2023.8961.
    >> Share

  221. THAWEETHAI T, Jolley SE, Karlson EW, Levitan EB, et al
    Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
    JAMA. 2023 May 25:e238823. doi: 10.1001/jama.2023.8823.
    >> Share

  222. HARRIS E
    CDC Updates COVID-19 Data Reporting as US Public Health Emergency Ends.
    JAMA. 2023 May 24. doi: 10.1001/jama.2023.9150.
    >> Share

  223. WEISS A, Donnachie E, Beyerlein A, Ziegler AG, et al
    Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19.
    JAMA. 2023 May 22:e238674. doi: 10.1001/jama.2023.8674.
    >> Share

  224. HARRIS E
    WHO Declares End of COVID-19 Global Health Emergency.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8656.
    >> Share

  225. HARRIS E
    COVID-19 Vaccine and Health Care Visits for Menstrual Changes.
    JAMA. 2023 May 17. doi: 10.1001/jama.2023.8658.
    >> Share

  226. ASHRAF S, Ashraf N
    Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19.
    JAMA. 2023;329:1702.
    >> Share

  227. MCCARTHY MW, Lindsell CJ, Naggie S
    Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply.
    JAMA. 2023;329:1702-1703.
    >> Share

  228. MARCUS R
    New Alzheimer Disease Drugs, Long COVID and the Central Nervous System, and a Nasal Spray for Migraines-Highlights From the 2023 American Academy of Neurology Conference.
    JAMA. 2023 May 10. doi: 10.1001/jama.2023.4389.
    >> Share

  229. HARRIS E
    BCG Vaccine Not Effective Against COVID-19.
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.7763.
    >> Share

  230. HARRIS E
    XBB.1.16 Deemed COVID-19 "Variant of Interest".
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.7768.
    >> Share

  231. LANDHUIS EW
    How Primary Care Physicians Can Recognize and Treat Long COVID.
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.6604.
    >> Share

  232. BOHRMANN B, Massa MS, Ross S, Lewington S, et al
    Body Mass Index and Risk of Hospitalization or Death Due to Lower or Upper Respiratory Tract Infection.
    JAMA. 2023;329:1512-1514.
    >> Share

  233. BOMMERSBACH TJ, McKean AJ, Olfson M, Rhee TG, et al
    National Trends in Mental Health-Related Emergency Department Visits Among Youth, 2011-2020.
    JAMA. 2023;329:1469-1477.
    >> Share

    April 2023
  234. HARRIS E
    FDA Simplifies COVID-19 Vaccination, Permits Some Additional Doses.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6624.
    >> Share

  235. HARRIS E
    How Parents' Views Are Tied to Children's COVID-19 Vaccination.
    JAMA. 2023 Apr 19. doi: 10.1001/jama.2023.6292.
    >> Share

  236. SPUNGEN H, Burton J, Schenkel S, Schriger DL, et al
    Completeness and Spin of medRxiv Preprint and Associated Published Abstracts of COVID-19 Randomized Clinical Trials.
    JAMA. 2023;329:1310-1312.
    >> Share

  237. HARRIS E
    Updated WHO Guidance for Prioritizing COVID-19 Vaccines.
    JAMA. 2023 Apr 12. doi: 10.1001/jama.2023.6256.
    >> Share

  238. LEE MMY, McMurray JJV
    Lack of Benefit of Renin-Angiotensin System Inhibitors in COVID-19.
    JAMA. 2023;329:1155-1156.
    >> Share

  239. SELF WH, Shotwell MS, Gibbs KW, de Wit M, et al
    Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
    JAMA. 2023;329:1170-1182.
    >> Share

  240. LAWLER PR, Derde LPG, van de Veerdonk FL, McVerry BJ, et al
    Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
    JAMA. 2023;329:1183-1196.
    >> Share

  241. XIE Y, Choi T, Al-Aly Z
    Risk of Death in Patients Hospitalized for COVID-19 vs Seasonal Influenza in Fall-Winter 2022-2023.
    JAMA. 2023 Apr 6. doi: 10.1001/jama.2023.5348.
    >> Share

  242. HARRIS E
    Study: US COVID-19 Outcomes Tied to State Characteristics and Policies.
    JAMA. 2023 Apr 5. doi: 10.1001/jama.2023.5622.
    >> Share

  243. AMMIRATI E, Moslehi JJ
    Diagnosis and Treatment of Acute Myocarditis: A Review.
    JAMA. 2023;329:1098-1113.
    >> Share

  244. HARRIS E
    Public Had Most Trust in Advice From Physicians, Nurses During Pandemic.
    JAMA. 2023;329:1053.
    >> Share

  245. HARRIS E
    "Living" Systematic Review of Mental Health During Pandemic.
    JAMA. 2023;329:1054.
    >> Share

  246. ESMAIL LC, Kapp P, Assi R, Wood J, et al
    Sharing of Individual Patient-Level Data by Trialists of Randomized Clinical Trials of Pharmacological Treatments for COVID-19.
    JAMA. 2023 Apr 3:e234590. doi: 10.1001/jama.2023.4590.
    >> Share

    March 2023
  247. HARRIS E
    Cold Virus Provided Cross-reactivity Against SARS-CoV-2 in Children.
    JAMA. 2023 Mar 29. doi: 10.1001/jama.2023.5261.
    >> Share

  248. CAMPO R
    Illness Metaphors and COVID-19.
    JAMA. 2023;329:1035.
    >> Share

  249. HARRIS E
    Nasally Administered Monoclonal Antibody for COVID-19.
    JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4000.
    >> Share

  250. GOLIGHER EC, Lawler PR, Jensen TP, Talisa V, et al
    Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19.
    JAMA. 2023 Mar 21. doi: 10.1001/jama.2023.3651.
    >> Share

  251. LONDON AJ, Seymour CW
    The Ethics of Clinical Research: Managing Persistent Uncertainty.
    JAMA. 2023;329:884-885.
    >> Share

  252. COKER TR, Cheng TL, Ybarra M
    Addressing the Long-term Effects of the COVID-19 Pandemic on Children and Families: A Report From the National Academies of Sciences, Engineering, and Medicine.
    JAMA. 2023 Mar 16. doi: 10.1001/jama.2023.4371.
    >> Share

  253. HARRIS E
    FDA Approves First Over-the-counter Combined COVID-19 and Flu Test.
    JAMA. 2023 Mar 8. doi: 10.1001/jama.2023.3192.
    >> Share

  254. SURAN M
    Long COVID Linked With Unemployment in New Analysis.
    JAMA. 2023;329:701-702.
    >> Share

  255. RUBIN R
    Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.0158.
    >> Share

  256. HARRIS E
    Meta-analysis: COVID-19 Infection Protects Against Severe Disease.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2885.
    >> Share

  257. HARRIS E
    Prior COVID-19 Infection Tied to Lasting Lung Abnormalities.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.2886.
    >> Share

    February 2023
  258. NEPRASH HT, Golberstein E, Ganguli I, Chernew ME, et al
    Association of Evaluation and Management Payment Policy Changes With Medicare Payment to Physicians by Specialty.
    JAMA. 2023;329:662-669.
    >> Share

  259. HARRIS E
    Study: No New SARS-CoV-2 Variants in Recent Outbreak in China.
    JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2089.
    >> Share

  260. HARRIS E
    COVID-19 Vaccination During Pregnancy Protected Infants.
    JAMA. 2023 Feb 22. doi: 10.1001/jama.2023.2098.
    >> Share

  261. LARKIN H
    National Academies: Expand US Wastewater Disease Surveillance.
    JAMA. 2023;329:531.
    >> Share

  262. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
    Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2023 Feb 20:e231650. doi: 10.1001/jama.2023.1650.
    >> Share

  263. BIBBINS-DOMINGO K, Malani PN
    At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19.
    JAMA. 2023 Feb 20. doi: 10.1001/jama.2023.1922.
    >> Share

  264. HARRIS E
    NIH Considers Lessons Learned During COVID-19 Pandemic.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1553.
    >> Share

  265. HARRIS E
    Most COVID-19 Deaths Worldwide Were Among Older People.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2023.1554.
    >> Share

  266. RUBIN R
    Questions Remain About What SARS-CoV-2 Variants Should Go Into the Annual COVID-19 Vaccines Proposed by the FDA.
    JAMA. 2023 Feb 15. doi: 10.1001/jama.2022.22285.
    >> Share

  267. CHANG R
    SARS-CoV-2 Infection and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents.
    JAMA. 2023;329:512.
    >> Share

  268. REWERS M, Ziegler AG
    SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents-Reply.
    JAMA. 2023;329:512-513.
    >> Share

  269. HARRIS E
    Updated COVID-19 Guidance for People Who Are Immunocompromised.
    JAMA. 2023 Feb 8. doi: 10.1001/jama.2023.1176.
    >> Share

  270. HONG KH, Sung H
    SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents.
    JAMA. 2023;329:424-425.
    >> Share

  271. CHU WM, Wang CY, Wei JC
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2023;329:426.
    >> Share

  272. WAGGONER JJ, Tyburski EA, Lam WA
    SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents-Reply.
    JAMA. 2023;329:425-426.
    >> Share

  273. HUH K, Kim YE, Jung J
    Vaccination, Acute Myocardial Infarction, and Ischemic Stroke After COVID-19 Infection-Reply.
    JAMA. 2023;329:426-427.
    >> Share

  274. LARKIN H
    Newly Discovered Host-Cell Factor Could Be a COVID-19 Treatment Target.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0748.
    >> Share

  275. LARKIN H
    High COVID-19 Rates Prompt Call for Better Nursing Home Protections.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0740.
    >> Share

  276. LARKIN H
    Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2023.0743.
    >> Share

    January 2023
  277. ROLFES MA, Talbot HK, McLean HQ, Stockwell MS, et al
    Household Transmission of Influenza A Viruses in 2021-2022.
    JAMA. 2023 Jan 26. doi: 10.1001/jama.2023.0064.
    >> Share

  278. HARRIS E
    NIH Funds Research on Severe COVID-19-Related Illness in Children.
    JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0391.
    >> Share

  279. RUBIN R
    Large Cohort Study Finds Possible Association Between Postural Orthostatic Tachycardia Syndrome and COVID-19 Vaccination but Far Stronger Link With SARS-CoV-2 Infection.
    JAMA. 2023 Jan 25. doi: 10.1001/jama.2023.0050.
    >> Share

  280. LARKIN HD
    Patients With Mild COVID-19 at Risk of Some Post-COVID-19 Condition Symptoms.
    JAMA. 2023 Jan 18. doi: 10.1001/jama.2022.24498.
    >> Share

  281. LARKIN HD
    NIH Pilots Telehealth Program for COVID-19.
    JAMA. 2023 Jan 18. doi: 10.1001/jama.2022.24494.
    >> Share

  282. BHIMRAJ A, Gallagher JC
    Lack of Benefit of Fluvoxamine for COVID-19.
    JAMA. 2023 Jan 12. doi: 10.1001/jama.2022.23954.
    >> Share

  283. MCCARTHY MW, Naggie S, Boulware DR, Lindsell CJ, et al
    Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2023 Jan 12. doi: 10.1001/jama.2022.24100.
    >> Share

  284. RUBIN R
    Swab the Throat as Well as the Nose? The Debate Over the Best Way to Test for SARS-CoV-2.
    JAMA. 2023 Jan 11. doi: 10.1001/jama.2022.23311.
    >> Share

  285. HOLMGREN AJ, Byron ME, Grouse CK, Adler-Milstein J, et al
    Association Between Billing Patient Portal Messages as e-Visits and Patient Messaging Volume.
    JAMA. 2023 Jan 6. doi: 10.1001/jama.2022.24710.
    >> Share

  286. LARKIN H
    Combined COVID-19 and Flu Test Authorized for Point-of-Care Use.
    JAMA. 2023;329:14-15.
    >> Share

    December 2022
  287. SURAN M
    VA Finds Nirmatrelvir Associated With Lower Risk of Long COVID.
    JAMA. 2022;328:2386.
    >> Share

  288. SURAN M
    HHS Releases New Report on Long COVID Experiences.
    JAMA. 2022;328:2386.
    >> Share

  289. YII CY, Yong SB, Wei JC
    COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients.
    JAMA. 2022;328:2457-2458.
    >> Share

  290. LO RE V 3RD, Dutcher SK, Cocoros NM
    COVID-19 vs Influenza for Risk of Thrombotic Events in Hospitalized Patients-Reply.
    JAMA. 2022;328:2458-2459.
    >> Share

  291. SLOMSKI A
    Angiotensin Receptor Blockers Not Effective Against COVID-19.
    JAMA. 2022;328:2387.
    >> Share

  292. SLOMSKI A
    Moderna COVID-19 Vaccine Safe and Effective for Children 6 Months to 5 Years.
    JAMA. 2022;328:2388.
    >> Share

  293. MANGURIAN C
    Getting Treated for COVID-19 Shouldn't Be This Difficult.
    JAMA. 2022 Dec 22. doi: 10.1001/jama.2022.23155.
    >> Share

  294. LARKIN H
    Dogs May Reliably Detect SARS-CoV-2 Infections at Mass Events.
    JAMA. 2022;328:2294.
    >> Share

  295. LARKIN H
    How Early COVID-19 Restrictions Effected Progress on Neglected Tropical Diseases.
    JAMA. 2022;328:2294-2295.
    >> Share

  296. BARNETT ML, Sax PE
    Long-term Follow-up After Critical COVID-19: REMAP-CAP Revisited.
    JAMA. 2022 Dec 16. doi: 10.1001/jama.2022.23700.
    >> Share

  297. HIGGINS AM, Berry LR, Lorenzi E, Murthy S, et al
    Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
    JAMA. 2022 Dec 16. doi: 10.1001/jama.2022.23257.
    >> Share

  298. ABBASI J
    Amid Ohio Measles Outbreak, New Global Report Warns of Decreased Vaccination During COVID-19 Pandemic.
    JAMA. 2022 Dec 15. doi: 10.1001/jama.2022.23241.
    >> Share

  299. MARKS PW, Gruppuso PA, Adashi EY
    Urgent Need for Next-Generation COVID-19 Vaccines.
    JAMA. 2022 Dec 9. doi: 10.1001/jama.2022.22759.
    >> Share

  300. LARKIN HD
    Novavax COVID-19 Vaccine Booster Authorized.
    JAMA. 2022;328:2101.
    >> Share

  301. BRUZELIUS E, Martins SS
    US Trends in Drug Overdose Mortality Among Pregnant and Postpartum Persons, 2017-2020.
    JAMA. 2022;328:2159-2161.
    >> Share

  302. BUENO DE MESQUITA PJ, Sokas R
    SARS-CoV-2 Reduction in Shared Indoor Air.
    JAMA. 2022;328:2163.
    >> Share

  303. SRIKRISHNA D, Karan A, Dhillon RS
    SARS-CoV-2 Reduction in Shared Indoor Air.
    JAMA. 2022;328:2162-2163.
    >> Share

  304. MANMADHAN A, Ahuja T
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022;328:2164-2165.
    >> Share

  305. DOWELL D, Lindsley WG, Brooks JT
    SARS-CoV-2 Reduction in Shared Indoor Air-Reply.
    JAMA. 2022;328:2163-2164.
    >> Share

  306. MACK CD, Anderson DJ, DiFiori J
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Cohort of Players and Staff in the National Basketball Association-Reply.
    JAMA. 2022;328:2165.
    >> Share

  307. GANDHI RT, Bedimo R, Hoy JF, Landovitz RJ, et al
    Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
    JAMA. 2022 Dec 1. doi: 10.1001/jama.2022.22246.
    >> Share

    November 2022
  308. ABBASI J
    Highlights From the American Heart Association's Scientific Sessions 2022-COVID-19's Ripple Effects, a Triglyceride Disappointment, Gene Editing Advances, and More.
    JAMA. 2022 Nov 23. doi: 10.1001/jama.2022.17757.
    >> Share

  309. SLOMSKI A
    Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial.
    JAMA. 2022;328:2003.
    >> Share

  310. BILINSKI A, Thompson K, Emanuel E
    COVID-19 and Excess All-Cause Mortality in the US and 20 Comparison Countries, June 2021-March 2022.
    JAMA. 2022 Nov 18. pii: 2798990. doi: 10.1001/jama.2022.21795.
    >> Share

  311. RUBIN R
    How Immune-Evasive Omicron Offspring and a Lack of Mitigation Measures Could Shape a COVID-19 Winter Wave.
    JAMA. 2022 Nov 16. pii: 2798913. doi: 10.1001/jama.2022.17758.
    >> Share

  312. YEK C, Kadri SS
    Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.
    JAMA. 2022;328:1977.
    >> Share

  313. FAUST JS, Renton B, Du C
    Massachusetts Data on Excess Mortality During the Delta and Omicron Waves of COVID-19.
    JAMA. 2022;328:1977-1978.
    >> Share

  314. LARKIN HD
    COVID-19 Limited Access to Sexual and Reproductive Health Services.
    JAMA. 2022;328:1896-1897.
    >> Share

  315. SURAN M
    Highlights From Infectious Disease Week 2022-COVID-19, HIV, Monkeypox, and Polio.
    JAMA. 2022 Nov 9. pii: 2798547. doi: 10.1001/jama.2022.17754.
    >> Share

  316. KUEHN BM
    Second COVID-19 Booster Increases Protection for Nursing Home Patients.
    JAMA. 2022;328:1800-1801.
    >> Share

    October 2022
  317. BERNARD SA, Bray JE, Smith K, Stephenson M, et al
    Effect of Lower vs Higher Oxygen Saturation Targets on Survival to Hospital Discharge Among Patients Resuscitated After Out-of-Hospital Cardiac Arrest: The EXACT Randomized Clinical Trial.
    JAMA. 2022 Oct 26. pii: 2798013. doi: 10.1001/jama.2022.17701.
    >> Share

  318. SURAN M
    VA Guidebook on Long COVID.
    JAMA. 2022;328:1580.
    >> Share

  319. SLOMSKI A
    Vitamin D Supplements Don't Reduce COVID-19 Risk.
    JAMA. 2022;328:1581.
    >> Share

  320. WALKER MD, Shane E
    Hypercalcemia: A Review.
    JAMA. 2022;328:1624-1636.
    >> Share

  321. FRIEDEN TR, McClelland A
    Preparing for Pandemics and Other Health Threats: Societal Approaches to Protect and Improve Health.
    JAMA. 2022;328:1585-1586.
    >> Share

  322. EISENBERG MD, Eddelbuettel JCP, McGinty EE
    Employment in Office-Based and Intensive Behavioral Health Settings in the US, 2016-2021.
    JAMA. 2022;328:1642-1643.
    >> Share

  323. NAGGIE S, Boulware DR, Lindsell CJ, Stewart TG, et al
    Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2022 Oct 21. pii: 2797483. doi: 10.1001/jama.2022.18590.
    >> Share

  324. JIANG Q, Zhang YF, Hu P
    Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel.
    JAMA. 2022;328:1561-1562.
    >> Share

  325. SHAVIT I, Koppel JH, Levy N
    Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel-Reply.
    JAMA. 2022;328:1562.
    >> Share

  326. THOMPSON MG, Yoon SK, Naleway AL, Meece J, et al
    Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers.
    JAMA. 2022;328:1523-1533.
    >> Share

  327. BELLANDI D
    Estimate: 10.5 Million Children Lost a Parent, Caregiver to COVID-19.
    JAMA. 2022;328:1490.
    >> Share

  328. HSU CK, Lai CC
    Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant.
    JAMA. 2022;328:1460.
    >> Share

  329. DORABAWILA V, Bassett MT, Rosenberg ES
    Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant-Reply.
    JAMA. 2022;328:1460-1461.
    >> Share

  330. KUEHN BM
    Lowest US Life Expectancy Since 1996 Linked to COVID-19.
    JAMA. 2022;328:1389.
    >> Share

  331. WULF HANSON S, Abbafati C, Aerts JG, Al-Aly Z, et al
    Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    JAMA. 2022 Oct 10. pii: 2797443. doi: 10.1001/jama.2022.18931.
    >> Share

  332. ABBASI J
    White House Advisor Nahid Bhadelia, MD, MALD, on COVID-19 in Resource-Limited Nations-Undercounted Deaths, Vaccine Inequity, and More.
    JAMA. 2022 Oct 5. pii: 2797281. doi: 10.1001/jama.2022.13663.
    >> Share

  333. SLOMSKI A
    Long COVID in Children.
    JAMA. 2022;328:1288.
    >> Share

  334. GERSHENGORN HB
    Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure.
    JAMA. 2022;328:1353-1354.
    >> Share

  335. RAGHUNATHAN K, Raghunathan A
    Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure.
    JAMA. 2022;328:1354.
    >> Share

  336. ALHAZZANI W, Weatherald J, Arabi YM
    Effect of Awake Prone Positioning on Patients With COVID-19 and Acute Respiratory Failure-Reply.
    JAMA. 2022;328:1354-1355.
    >> Share

    September 2022
  337. GARDNER L
    The COVID-19 Dashboard for Real-time Tracking of the Pandemic: The Lasker-Bloomberg Public Service Award.
    JAMA. 2022 Sep 28. pii: 2796722. doi: 10.1001/jama.2022.15590.
    >> Share

  338. NICHOL AD, O'Kane C, McAuley DF
    Respiratory Support in the Time of COVID-19.
    JAMA. 2022;328:1203-1205.
    >> Share

  339. SLOMSKI A
    Repurposed Drugs Failed to Prevent Severe COVID-19.
    JAMA. 2022;328:1171.
    >> Share

  340. FRAT JP, Quenot JP, Badie J, Coudroy R, et al
    Effect of High-Flow Nasal Cannula Oxygen vs Standard Oxygen Therapy on Mortality in Patients With Respiratory Failure Due to COVID-19: The SOHO-COVID Randomized Clinical Trial.
    JAMA. 2022;328:1212-1222.
    >> Share

  341. KUEHN BM
    Bus and Urban Transit Workers Have Highest COVID-19 Risk.
    JAMA. 2022;328:1173.
    >> Share

  342. KELLY JD, Leonard S, Hoggatt KJ, Boscardin WJ, et al
    Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines.
    JAMA. 2022 Sep 26. pii: 2796892. doi: 10.1001/jama.2022.17985.
    >> Share

  343. TENFORDE MW, Link-Gelles R, Patel MM
    Long-term Protection Associated With COVID-19 Vaccination and Prior Infection.
    JAMA. 2022 Sep 26. pii: 2796894. doi: 10.1001/jama.2022.14660.
    >> Share

  344. LIN DY, Gu Y, Xu Y, Wheeler B, et al
    Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes.
    JAMA. 2022 Sep 26. pii: 2796893. doi: 10.1001/jama.2022.17876.
    >> Share

  345. RIDGWAY JP, Tideman S, French T, Wright B, et al
    Odds of Hospitalization for COVID-19 After 3 vs 2 Doses of mRNA COVID-19 Vaccine by Time Since Booster Dose.
    JAMA. 2022 Sep 23. pii: 2796847. doi: 10.1001/jama.2022.17811.
    >> Share

  346. RUBIN R
    The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?
    JAMA. 2022 Sep 21. pii: 2796806. doi: 10.1001/jama.2022.15062.
    >> Share

  347. ARABI YM, Aldekhyl S, Al Qahtani S, Al-Dorzi HM, et al
    Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19: The HELMET-COVID Randomized Clinical Trial.
    JAMA. 2022;328:1063-1072.
    >> Share

  348. LARKIN HD
    COVID-19 Health Policies and Economies in Nordic Countries.
    JAMA. 2022;328:1029.
    >> Share

  349. MATTA S, Nicholas LH
    Changes in Unemployment Among Health Care Workers Following the COVID-19 Pandemic.
    JAMA. 2022 Sep 19. pii: 2796661. doi: 10.1001/jama.2022.17608.
    >> Share

  350. LARKIN HD
    New Data on Heterologous COVID-19 Vaccine Combinations.
    JAMA. 2022;328:916-917.
    >> Share

  351. LARKIN HD
    Antibody Found in Mice Neutralizes SARS-CoV-2 and SARS-CoV-1.
    JAMA. 2022;328:916-917.
    >> Share

  352. KUEHN BM
    CDC Streamlines COVID-19 Guidance.
    JAMA. 2022;328:918-919.
    >> Share

  353. WEBBER C, Myran DT, Milani C, Turcotte L, et al
    Cognitive Decline in Long-term Care Residents Before and During the COVID-19 Pandemic in Ontario, Canada.
    JAMA. 2022 Sep 12. pii: 2796449. doi: 10.1001/jama.2022.17214.
    >> Share

  354. ABBASI J
    The US Now Has a Research Plan for Long COVID-Is It Enough?
    JAMA. 2022;328:812-814.
    >> Share

    August 2022
  355. BARNETT ML, Waken RJ, Zheng J, Orav EJ, et al
    Changes in Health and Quality of Life in US Skilled Nursing Facilities by COVID-19 Exposure Status in 2020.
    JAMA. 2022 Aug 29. pii: 2795935. doi: 10.1001/jama.2022.15071.
    >> Share

  356. YOUNGSTER I
    Self-sampling for SARS-CoV-2 Detection in Children.
    JAMA. 2022 Aug 26. pii: 2795838. doi: 10.1001/jama.2022.15225.
    >> Share

  357. WAGGONER JJ, Vos MB, Tyburski EA, Nguyen PV, et al
    Concordance of SARS-CoV-2 Results in Self-collected Nasal Swabs vs Swabs Collected by Health Care Workers in Children and Adolescents.
    JAMA. 2022 Aug 26. pii: 2795837. doi: 10.1001/jama.2022.14877.
    >> Share

  358. SOLIS-MOREIRA J
    Study: New Wastewater Surveillance Method Detected SARS-CoV-2 Variants of Concern Up to 2 Weeks Before Clinical Tests.
    JAMA. 2022 Aug 24. pii: 2795815. doi: 10.1001/jama.2022.12563.
    >> Share

  359. RUBIN R
    Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US.
    JAMA. 2022 Aug 24. pii: 2795814. doi: 10.1001/jama.2022.13661.
    >> Share

  360. SURAN M
    Free COVID-19 Tests for People With Visual Impairment.
    JAMA. 2022;328:699.
    >> Share

  361. SLOMSKI A
    Antibody Testing's Limits for Detecting Prior SARS-CoV-2 Infection.
    JAMA. 2022;328:700-701.
    >> Share

  362. RUBIN R
    Pharmacists Allowed to Prescribe COVID-19 Antiviral.
    JAMA. 2022;328:612.
    >> Share

  363. LO RE V 3RD, Dutcher SK, Connolly JG, Perez-Vilar S, et al
    Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients.
    JAMA. 2022;328:637-651.
    >> Share

  364. LARKIN HD
    Preventing COVID-19, Saving Lives in Lower-Income Countries.
    JAMA. 2022;328:611.
    >> Share

  365. KUEHN BM
    Reduced HIV Testing and Diagnoses During COVID-19 Pandemic.
    JAMA. 2022;328:519.
    >> Share

  366. LARKIN HD
    Evolving Omicron Subvariants Are More Resistant to Antibody Therapy.
    JAMA. 2022;328:518.
    >> Share

  367. REWERS M, Bonifacio E, Ewald D, Geno Rasmussen C, et al
    SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany.
    JAMA. 2022 Aug 5. pii: 2795226. doi: 10.1001/jama.2022.14092.
    >> Share

  368. MADHUSOODANAN J
    Animal Reservoirs-Where the Next SARS-CoV-2 Variant Could Arise.
    JAMA. 2022 Aug 3. pii: 2795140. doi: 10.1001/jama.2022.9789.
    >> Share

  369. LEVINE RL
    Addressing the Long-term Effects of COVID-19.
    JAMA. 2022 Aug 3. pii: 2795139. doi: 10.1001/jama.2022.14089.
    >> Share

  370. SLOMSKI A
    Sickle Cell Trait Associated With Kidney Failure and COVID-19 Death.
    JAMA. 2022;328:415.
    >> Share

  371. SLOMSKI A
    Maternal Death Rate Increased During Early COVID-19 Pandemic.
    JAMA. 2022;328:415.
    >> Share

  372. GENZEN JR, Rychert J, George TI
    Integrity of SARS-CoV-2 Laboratory-Developed Tests.
    JAMA. 2022;328:478.
    >> Share

  373. ADASHI EY, Cohen G
    Integrity of SARS-CoV-2 Laboratory-Developed Tests-Reply.
    JAMA. 2022;328:478-479.
    >> Share

  374. BIRNIE E, Biemond JJ, Appelman B, de Bree GJ, et al
    Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.
    JAMA. 2022 Aug 1. pii: 2794999. doi: 10.1001/jama.2022.13854.
    >> Share

    July 2022
  375. VASAN A, Foote M, Long T
    Ensuring Widespread and Equitable Access to Treatments for COVID-19.
    JAMA. 2022 Jul 29. pii: 2794967. doi: 10.1001/jama.2022.13554.
    >> Share

  376. ZENG G
    SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
    JAMA. 2022;328:395.
    >> Share

  377. ULLOA AC, Buchan SA, Brown KA
    SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.
    JAMA. 2022;328:395-396.
    >> Share

  378. SLOMSKI A
    Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults.
    JAMA. 2022;328:322.
    >> Share

  379. KUEHN BM
    Persistent Disparities in COVID-19 Antiviral Dispensing.
    JAMA. 2022;328:323.
    >> Share

  380. MALANI AG, Malani AN
    Preventive Medication for COVID-19 Infection.
    JAMA. 2022 Jul 25. pii: 2794799. doi: 10.1001/jama.2022.13214.
    >> Share

  381. KIM YE, Huh K, Park YJ, Peck KR, et al
    Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection.
    JAMA. 2022 Jul 22. pii: 2794753. doi: 10.1001/jama.2022.12992.
    >> Share

  382. WEBER E, Van Buren N, Cunningham T
    COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge.
    JAMA. 2022;328:301-302.
    >> Share

  383. LIN HY, Chen MH, Liang CS
    COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge.
    JAMA. 2022;328:301.
    >> Share

  384. KENIK J
    Remote Patient Monitoring During COVID-19.
    JAMA. 2022;328:302-303.
    >> Share

  385. AZOULAY E, Pochard F, Kentish-Barnes N
    COVID-19 ARDS and Posttraumatic Stress Disorder in Family Members After ICU Discharge-Reply.
    JAMA. 2022;328:302.
    >> Share

  386. PRONOVOST PJ, Cole MD, Hughes RM
    Remote Patient Monitoring During COVID-19-Reply.
    JAMA. 2022;328:303-304.
    >> Share

  387. LARKIN HD
    Mix-and-Match COVID-19 Boosters After Inactivated Virus Vaccine.
    JAMA. 2022;328:234.
    >> Share

  388. RUBIN R
    COVID-19 Boosters This Fall to Include Omicron Antigen, but Questions Remain About Its Value.
    JAMA. 2022 Jul 8. pii: 2794259. doi: 10.1001/jama.2022.11252.
    >> Share

  389. SCHWANDT H, Currie J, von Wachter T, Kowarski J, et al
    Changes in the Relationship Between Income and Life Expectancy Before and During the COVID-19 Pandemic, California, 2015-2021.
    JAMA. 2022 Jul 7. pii: 2794146. doi: 10.1001/jama.2022.10952.
    >> Share

  390. LARKIN HD
    First Nonprescription COVID-19 Test That Also Detects Flu and RSV.
    JAMA. 2022;328:11.
    >> Share

  391. LARKIN HD
    Expiration Dates Extended on COVID-19 Monoclonal Antibody Therapies.
    JAMA. 2022;328:11.
    >> Share

  392. KUEHN BM
    WHO: Pandemic Sparked a Push for Global Mental Health Transformation.
    JAMA. 2022;328:5-7.
    >> Share

  393. AZZOLINI E, Levi R, Sarti R, Pozzi C, et al
    Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers.
    JAMA. 2022 Jul 1. pii: 2794072. doi: 10.1001/jama.2022.11691.
    >> Share

    June 2022
  394. RUDYM D, Chang SH, Angel LF
    Characteristics and Outcomes of Patients With COVID-19-Associated ARDS Who Underwent Lung Transplant.
    JAMA. 2022;327:2454.
    >> Share

  395. MANERIKAR A, Budinger GRS, Bharat A
    Characteristics and Outcomes of Patients With COVID-19-Associated ARDS Who Underwent Lung Transplant-Reply.
    JAMA. 2022;327:2454-2455.
    >> Share

  396. CARDOSO CC, Rossi AD, Galliez RM, Faffe DS, et al
    Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil.
    JAMA. 2022 Jun 24. pii: 2793811. doi: 10.1001/jama.2022.11006.
    >> Share

  397. ABBASI J
    COVID-19 mRNA Vaccine Booster During Pregnancy Increases Maternal and Fetal Antibodies.
    JAMA. 2022 Jun 22. pii: 2793740. doi: 10.1001/jama.2022.11145.
    >> Share

  398. RUBIN R
    Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment.
    JAMA. 2022;327:2281.
    >> Share

  399. LARKIN HD
    mRNA COVID-19 Vaccine Booster After Inactivated Vaccine Primary Series.
    JAMA. 2022;327:2280.
    >> Share

  400. KLOMPAS M, Pandolfi MC, Nisar AB, Baker MA, et al
    Association of Omicron vs Wild-type SARS-CoV-2 Variants With Hospital-Onset SARS-CoV-2 Infections in a US Regional Hospital System.
    JAMA. 2022 Jun 15. pii: 2793582. doi: 10.1001/jama.2022.9609.
    >> Share

  401. HAMAD R, Galea S
    The Role of Health Care Systems in Bolstering the Social Safety Net to Address Health Inequities in the Wake of the COVID-19 Pandemic.
    JAMA. 2022 Jun 15. pii: 2793581. doi: 10.1001/jama.2022.10160.
    >> Share

  402. LARKIN HD
    Urine Test Detects SARS-CoV-2 Antibodies.
    JAMA. 2022;327:2182.
    >> Share

  403. FARMAKIOTIS D
    COVID-19 Treatments for Nonhospitalized Patients.
    JAMA. 2022;327:2247.
    >> Share

  404. CAYLEY WE JR
    COVID-19 Treatments for Nonhospitalized Patients.
    JAMA. 2022;327:2248.
    >> Share

  405. GANDHI RT, Malani PN, Del Rio C
    COVID-19 Treatments for Nonhospitalized Patients-Reply.
    JAMA. 2022;327:2248.
    >> Share

  406. KATZ SE, Edwards K
    Protecting Children Against Omicron.
    JAMA. 2022;327:2195-2197.
    >> Share

  407. JONES JM, Opsomer JD, Stone M, Benoit T, et al
    Updated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Estimates Based on Blood Donations, July 2020-December 2021.
    JAMA. 2022 Jun 13. pii: 2793517. doi: 10.1001/jama.2022.9745.
    >> Share

  408. RUBIN R
    From Positive to Negative to Positive Again-The Mystery of Why COVID-19 Rebounds in Some Patients Who Take Paxlovid.
    JAMA. 2022 Jun 8. pii: 2793357. doi: 10.1001/jama.2022.9925.
    >> Share

  409. DOWELL D, Lindsley WG, Brooks JT
    Reducing SARS-CoV-2 in Shared Indoor Air.
    JAMA. 2022 Jun 7. pii: 2793289. doi: 10.1001/jama.2022.9970.
    >> Share

  410. LARKIN HD
    Warning Against Counterfeit At-home COVID-19 Tests.
    JAMA. 2022;327:2067.
    >> Share

  411. LI Y
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave.
    JAMA. 2022;327:2147-2148.
    >> Share

  412. LATRONICO N, Rasulo FA, Piva S
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
    JAMA. 2022;327:2149.
    >> Share

  413. BAI W, Jackson T, Xiang YT
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
    JAMA. 2022;327:2148-2149.
    >> Share

  414. SEVIN CM, Ely EW
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19.
    JAMA. 2022;327:2149-2150.
    >> Share

  415. MASLO C, Toubkin M
    Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave-Reply.
    JAMA. 2022;327:2148.
    >> Share

  416. HEESAKKERS H, van den Boogaard M, Zegers M
    Outcomes Among Patients With 1-Year Survival After Intensive Care Unit Treatment for COVID-19-Reply.
    JAMA. 2022;327:2150-2151.
    >> Share

  417. VIJAY A, Yancy CW
    Resident Physician Wellness Postpandemic: How Does Healing Occur?
    JAMA. 2022;327:2077-2078.
    >> Share

  418. TAI CG, Maragakis LL, Connolly S, DiFiori J, et al
    Association Between COVID-19 Booster Vaccination and Omicron Infection in a Highly Vaccinated Cohort of Players and Staff in the National Basketball Association.
    JAMA. 2022 Jun 2. pii: 2793169. doi: 10.1001/jama.2022.9479.
    >> Share

  419. RUBIN R
    Challenges of Deciding Whether and How to Update COVID-19 Vaccines to Protect Against Variants.
    JAMA. 2022 Jun 1. pii: 2793149. doi: 10.1001/jama.2022.9367.
    >> Share

    May 2022
  420. DEL RIO C, Malani PN
    COVID-19 in 2022-The Beginning of the End or the End of the Beginning?
    JAMA. 2022 May 27. pii: 2793011. doi: 10.1001/jama.2022.9655.
    >> Share

  421. WEISS SR
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
    JAMA. 2022;327:2019-2020.
    >> Share

  422. PEREZ-FERNANDEZ XL, Fuset-Cabanes M, Hernandez-Platero L
    Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.
    JAMA. 2022;327:2022-2023.
    >> Share

  423. YARNELL CJ, Sklar MC
    Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19.
    JAMA. 2022;327:2023.
    >> Share

  424. OSTER ME, Shay DK, Shimabukuro TT
    Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
    JAMA. 2022;327:2020-2021.
    >> Share

  425. COUPER K, Connolly BA, McAuley DF
    Noninvasive Respiratory Strategies and Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19-Reply.
    JAMA. 2022;327:2023-2024.
    >> Share

  426. KUEHN BM
    Cardiac Complications More Common After COVID-19 Than Vaccination.
    JAMA. 2022;327:1951.
    >> Share

  427. FAUST JS, Du C, Liang C, Mayes KD, et al
    Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19.
    JAMA. 2022 May 20. pii: 2792738. doi: 10.1001/jama.2022.8045.
    >> Share

  428. LEVY N, Koppel JH, Kaplan O, Yechiam H, et al
    Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel.
    JAMA. 2022 May 19. pii: 2792718. doi: 10.1001/jama.2022.8025.
    >> Share

  429. RUBIN R
    SARS-CoV-2 RNA Can Persist in Stool Months After Respiratory Tract Clears Virus.
    JAMA. 2022 May 18. pii: 2792688. doi: 10.1001/jama.2022.7892.
    >> Share

  430. BELLANDI D, Voelker R
    New White House COVID-19 Leader on What's Next.
    JAMA. 2022 May 18. pii: 2792686. doi: 10.1001/jama.2022.8541.
    >> Share

  431. RUBIN R
    First Breathalyzer Test to Diagnose COVID-19.
    JAMA. 2022;327:1860.
    >> Share

  432. BEZERRA MF
    Rapid Antigen Tests for SARS-CoV-2.
    JAMA. 2022;327:1925-1926.
    >> Share

  433. GANS JS, Goldfarb A, Rosella L
    Rapid Antigen Tests for SARS-CoV-2-Reply.
    JAMA. 2022;327:1926.
    >> Share

  434. SHIROKY-KOCHAVI J
    The Pandemic Determinants of Health.
    JAMA. 2022;327:1869.
    >> Share

  435. ALHAZZANI W, Parhar KKS, Weatherald J, Al Duhailib Z, et al
    Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial.
    JAMA. 2022 May 15. pii: 2792506. doi: 10.1001/jama.2022.7993.
    >> Share

  436. FLEMING-DUTRA KE, Britton A, Shang N, Derado G, et al
    Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.
    JAMA. 2022 May 13. pii: 2792524. doi: 10.1001/jama.2022.7493.
    >> Share

  437. DORABAWILA V, Hoefer D, Bauer UE, Bassett MT, et al
    Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.
    JAMA. 2022 May 13. pii: 2792525. doi: 10.1001/jama.2022.7319.
    >> Share

  438. HOURY DE, Simon TR, Crosby AE
    Firearm Homicide and Suicide During the COVID-19 Pandemic: Implications for Clinicians and Health Care Systems.
    JAMA. 2022 May 10. pii: 2792080. doi: 10.1001/jama.2022.6924.
    >> Share

  439. LARKIN HD
    Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3.
    JAMA. 2022;327:1748.
    >> Share

  440. LARKIN HD
    Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses.
    JAMA. 2022;327:1748.
    >> Share

  441. MANGURIAN C, Fitelson EM, Epel E
    COVID-19 and Lessons to Improve Preparedness for the Next Pandemic.
    JAMA. 2022;327:1822-1823.
    >> Share

  442. CHEN J, Al-Azzawi ZAM, Taifour T
    Testing, Surveillance, and Mitigation Strategies for COVID-19.
    JAMA. 2022;327:1824-1825.
    >> Share

  443. NUZZO JB, Gostin LO
    COVID-19 and Lessons to Improve Preparedness for the Next Pandemic-Reply.
    JAMA. 2022;327:1823.
    >> Share

  444. EMANUEL EJ, Michaels D, Bright RA
    Testing, Surveillance, and Mitigation Strategies for COVID-19-Reply.
    JAMA. 2022;327:1825.
    >> Share

  445. KUEHN BM
    mRNA Booster Improves a COVID-19 Vaccine's Effectiveness.
    JAMA. 2022;327:1749.
    >> Share

  446. GANDJOUR A
    Strategy for the "New Normal" of Life With COVID.
    JAMA. 2022;327:1823-1824.
    >> Share

  447. EMANUEL EJ, Osterholm M, Gounder CR
    Strategy for the "New Normal" of Life With COVID-Reply.
    JAMA. 2022;327:1824.
    >> Share

  448. SLOMSKI A
    Studies Examine Risk of Hearing Loss After COVID-19 Vaccination.
    JAMA. 2022;327:1641.
    >> Share

  449. MARKS P, Woodcock J, Califf R
    COVID-19 Vaccination-Becoming Part of the New Normal.
    JAMA. 2022 May 2. pii: 2792030. doi: 10.1001/jama.2022.7469.
    >> Share

  450. MCCLYMONT E, Albert AY, Alton GD, Boucoiran I, et al
    Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes.
    JAMA. 2022 May 2. pii: 2792031. doi: 10.1001/jama.2022.5906.
    >> Share

    April 2022
  451. RUBIN R
    The COVID-19 Pandemic Rages on for People Who Are Immunocompromised.
    JAMA. 2022 Apr 27. pii: 2791868. doi: 10.1001/jama.2022.7281.
    >> Share

  452. SURAN M
    White Individuals Experience Less COVID-19-Related Discrimination.
    JAMA. 2022;327:1538.
    >> Share

  453. KUEHN BM
    COVID-19 Vaccine Effectiveness in Youth Varies by Age, Variant.
    JAMA. 2022;327:1540.
    >> Share

  454. PETTY LA, Malani PN
    Oral Antiviral Medications for COVID-19.
    JAMA. 2022 Apr 25. pii: 2791780. doi: 10.1001/jama.2022.6876.
    >> Share

  455. RAZZAGHI H, Meghani M, Crane B, Ellington S, et al
    Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics.
    JAMA. 2022 Apr 22. pii: 2791659. doi: 10.1001/jama.2022.6834.
    >> Share

  456. SURAN M
    Stagnant US Mammography Rates and the Influence of COVID-19.
    JAMA. 2022 Apr 20. pii: 2791573. doi: 10.1001/jama.2022.4295.
    >> Share

  457. LARKIN HD
    Global COVID-19 Death Toll May Be Triple the Reported Deaths.
    JAMA. 2022;327:1438.
    >> Share

  458. LARKIN HD
    WHO Urges Monitoring SARS-CoV-2 in Wildlife to Prevent Animal Reservoirs.
    JAMA. 2022;327:1438.
    >> Share

  459. LARKIN HD
    Fractionating COVID-19 Vaccine Doses May Save Lives.
    JAMA. 2022;327:1438.
    >> Share

  460. WOLFSON AR, Freeman EE, Blumenthal KG
    Urticaria 12 Days After COVID-19 mRNA Booster Vaccination.
    JAMA. 2022 Apr 14. pii: 2791317. doi: 10.1001/jama.2022.5247.
    >> Share

  461. ABBASI J
    Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
    JAMA. 2022;327:1323.
    >> Share

  462. KUEHN BM
    Myocarditis Adverse Event Less Common After COVID-19 Vaccine Booster.
    JAMA. 2022;327:1324.
    >> Share

  463. ABBASI J
    Vaccine Booster Dose Appears to Reduce Omicron Hospitalizations.
    JAMA. 2022;327:1323.
    >> Share

  464. TSAY SV, Bartoces M, Gouin K, Kabbani S, et al
    Antibiotic Prescriptions Associated With COVID-19 Outpatient Visits Among Medicare Beneficiaries, April 2020 to April 2021.
    JAMA. 2022 Apr 8. pii: 2791077. doi: 10.1001/jama.2022.5471.
    >> Share

  465. BRADLEY MC, Perez-Vilar S, Chillarige Y, Dong D, et al
    Systemic Corticosteroid Use for COVID-19 in US Outpatient Settings From April 2020 to August 2021.
    JAMA. 2022 Apr 8. pii: 2791078. doi: 10.1001/jama.2022.4877.
    >> Share

  466. SLOMSKI A
    At-home COVID-19 Test Instructions Frequently Misinterpreted.
    JAMA. 2022;327:1218.
    >> Share

  467. SLOMSKI A
    Maternal COVID-19 Vaccine Safe for Infants.
    JAMA. 2022;327:1218.
    >> Share

  468. NISSEN SE, Wolski K, Balog C, Swerdlow DI, et al
    Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
    JAMA. 2022 Apr 3. pii: 2790912. doi: 10.1001/jama.2022.5050.
    >> Share

  469. NATTINO G, Castiglioni S, Cereda D, Della Valle PG, et al
    Association Between SARS-CoV-2 Viral Load in Wastewater and Reported Cases, Hospitalizations, and Vaccinations in Milan, March 2020 to November 2021.
    JAMA. 2022 Apr 1. pii: 2790911. doi: 10.1001/jama.2022.4908.
    >> Share

    March 2022
  470. SAGE WM, Yang YT
    Reducing "COVID-19 Misinformation" While Preserving Free Speech.
    JAMA. 2022 Mar 31. pii: 2790859. doi: 10.1001/jama.2022.4231.
    >> Share

  471. KHARBANDA EO, Vazquez-Benitez G
    COVID-19 mRNA Vaccines During Pregnancy: New Evidence to Help Address Vaccine Hesitancy.
    JAMA. 2022 Mar 24. pii: 2790610. doi: 10.1001/jama.2022.2459.
    >> Share

  472. ADHIKARI EH, MacDonald L, SoRelle JA, Morse J, et al
    COVID-19 Cases and Disease Severity in Pregnancy and Neonatal Positivity Associated With Delta (B.1.617.2) and Omicron (B.1.1.529) Variant Predominance.
    JAMA. 2022 Mar 24. pii: 2790609. doi: 10.1001/jama.2022.4356.
    >> Share

  473. MAGNUS MC, Ortqvist AK, Dahlqwist E, Ljung R, et al
    Association of SARS-CoV-2 Vaccination During Pregnancy With Pregnancy Outcomes.
    JAMA. 2022 Mar 24. pii: 2790608. doi: 10.1001/jama.2022.3271.
    >> Share

  474. FELL DB, Dhinsa T, Alton GD, Torok E, et al
    Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
    JAMA. 2022 Mar 24. pii: 2790607. doi: 10.1001/jama.2022.4255.
    >> Share

  475. ABBASI J
    Even Mild COVID-19 May Change the Brain.
    JAMA. 2022 Mar 23. pii: 2790595. doi: 10.1001/jama.2022.4507.
    >> Share

  476. SURAN M
    COVID-19 Booster Shot Data Now Available From Nursing Homes.
    JAMA. 2022;327:1117.
    >> Share

  477. BRADBURY CA, Lawler PR, Stanworth SJ, McVerry BJ, et al
    Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
    JAMA. 2022 Mar 22. pii: 2790488. doi: 10.1001/jama.2022.2910.
    >> Share

  478. CONNORS JM, Ridker PM
    Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status.
    JAMA. 2022 Mar 22. pii: 2790489. doi: 10.1001/jama.2022.2361.
    >> Share

  479. STEAD W
    One Person.
    JAMA. 2022;327:1131-1132.
    >> Share

  480. WHITE AM, Castle IP, Powell PA, Hingson RW, et al
    Alcohol-Related Deaths During the COVID-19 Pandemic.
    JAMA. 2022 Mar 18. pii: 2790491. doi: 10.1001/jama.2022.4308.
    >> Share

  481. LIEBOWITZ JE, Konig MF
    Joint Pain in a Woman Wearing a Face Mask.
    JAMA. 2022 Mar 17. pii: 2790422. doi: 10.1001/jama.2022.2644.
    >> Share

  482. FRIEDENSOHN L, Levin D, Fadlon-Derai M, Gershovitz L, et al
    Myocarditis Following a Third BNT162b2 Vaccination Dose in Military Recruits in Israel.
    JAMA. 2022 Mar 17. pii: 2790421. doi: 10.1001/jama.2022.4425.
    >> Share

  483. LI J, Pavlov I, Ehrmann S
    High-Flow Oxygen vs Conventional Oxygen and Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19.
    JAMA. 2022;327:1092.
    >> Share

  484. OSPINA-TASCON GA, Martinez D, Gempeler A
    High-Flow Oxygen vs Conventional Oxygen and Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19-Reply.
    JAMA. 2022;327:1092-1093.
    >> Share

  485. LARKIN HD
    WHO Releases Report on Maintaining Health Services During COVID-19.
    JAMA. 2022;327:1019.
    >> Share

  486. GUPTA A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, et al
    Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    JAMA. 2022 Mar 14. pii: 2790246. doi: 10.1001/jama.2022.2832.
    >> Share

  487. COREY L, Corbett-Detig R, Beyrer C
    Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics.
    JAMA. 2022 Mar 11. pii: 2790239. doi: 10.1001/jama.2022.3517.
    >> Share

  488. RUBIN R
    Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor.
    JAMA. 2022 Mar 9. pii: 2790074. doi: 10.1001/jama.2022.3214.
    >> Share

  489. KUEHN BM
    Racial and Ethnic, Gender Disparities Seen in LGBT COVID-19 Vaccination Rates.
    JAMA. 2022;327:910.
    >> Share

  490. JORGENSEN SB, Nygard K, Kacelnik O, Telle K, et al
    Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households.
    JAMA. 2022 Mar 7. pii: 2789920. doi: 10.1001/jama.2022.3780.
    >> Share

  491. ADASHI EY, Cohen IG
    SARS-CoV-2 Laboratory-Developed Tests: Integrity Restored.
    JAMA. 2022 Mar 4. pii: 2789917. doi: 10.1001/jama.2022.3382.
    >> Share

  492. TONELLI M, Warick R
    Focusing on the Needs of People With Hearing Loss During the COVID-19 Pandemic and Beyond.
    JAMA. 2022 Mar 3. pii: 2789772. doi: 10.1001/jama.2022.3026.
    >> Share

  493. ABBASI J
    The COVID Heart-One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks.
    JAMA. 2022 Mar 2. pii: 2789793. doi: 10.1001/jama.2022.2411.
    >> Share

  494. SLOMSKI A
    Metabolic Surgery Associated With Less Severe COVID-19.
    JAMA. 2022;327:804.
    >> Share

  495. GOMES T, Campbell TJ, Kitchen SA, Garg R, et al
    Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
    JAMA. 2022;327:846-855.
    >> Share

  496. BROOKS MM, Wisniewski SR
    Assessing Unexpected Circumstances That Lead to Modifications in Clinical Trial Design, Conduct, or Analysis: Application of the CONSERVE Reporting Guideline.
    JAMA. 2022;327:868-869.
    >> Share

    October 2021
  497. RADWANY S
    Our Best Judgment.
    JAMA. 2021;326:1373-1374.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016